|
|
|
| 8:00 - 18:00 |
|
Registration, Lobby of the Auditorium Maximum |
| 8:30 - 9:00 |
|
Opening Remarks by Horst Domdey, Scientific Director of BayGene
State Minister Dr. Thomas Goppel, Bavarian State Ministry for Sience, Research and the Arts (requested)
Wolfgang A. Herrmann, President Technical University Munich (requested)
|
|
|
|
| 9:00 - 9:35 |
|
Mapping Signal Transduction Pathways by Proteomics
Walter Kolch
Beatson Institute for Cancer Research, Glasgow, Scotland |
| 9:35 - 10:10 |
|
Spatiotemporal Regulation of EGFR/MAP Kinase Signaling
Lukas Huber
Biocenter, Division of Cell Biology, Medical University Innsbruck, Austria
|
| 10:10 - 10:45 |
|
Targeting Ubiquitin Signaling in Cancer
Ivan Dikic
Institute of Biochemistry, Goethe University Medical School, Frankfurt am Main, Germany |
| 10:45 - 11:15 |
|
Coffee Break - Visit also the Exhibition and Posters |
| 11:15 - 11:50 |
|
Towards an Understanding of BRAF Signaling in Melanoma
Richard Marais
The Institute of Cancer Research, London, UK |
| 11:50 - 12:25 |
|
The RNAi Strategy in Cancer: Towards the Achilles Heal of Cancer
Roderick L. Beijersbergen
he Netherlands Cancer Institute Division of Molecular Carcinogenesis Amsterdam, The Netherlands |
| 12:25 - 13:00 |
|
Challenges and Applications of High-Throughput RNA Interference Screens
Bernard Mathey-Prevot
Drosophila RNAi Screening Center, Dept. of Genetics, Harvard Medical School Boston, MA, USA |
| 13:00 - 14:00 |
|
Lunch Break |
|
|
|
| 14:00 - 14:30 |
|
OncoGenome Analysis as Basis for Cancer Target Identification and Development
of Novel Therapies
Axel Ullrich
Max-Planck-Institute of Biochemistry, Martinsried, Germany |
| 14:30 - 15:00 |
|
Chromosomal Instability through Wnt Signaling
Juergen Behrens
Nikolaus-Fiebiger-Center of Molecular Medicine University of Erlangen, Germany |
| 15:00 - 15:30 |
|
A New Strategy for Searching Biomarkers in Plasma Using Biobanks and
Quantitative Proteomics
Friedrich Lottspeich
Max-Planck-Institute of Biochemistry, Martinsried, Germany |
| 15:30 - 16:00 |
|
Molecular Mechanisms of Melanoma Development
Anja Bosserhoff
Institute of Pathology University of Regensburg, Germany |
| 16:00 - 16:30 |
|
Coffee Break - Visit also the Exhibition and Posters |
|
|
|
| 16:30 - 17:05 |
|
Molecular Imaging in NeuroOncology
Andreas H. Jacobs
Department of Neurology,
Klinikum Fulda, and Laboratory for Gene Therapy and Molecular Imaging
MPI for Neurological Research, Cologne, Germany |
| 17:05 - 17:45 |
|
Molecular and Functional Imaging of Cancer
Kristine Glunde
Radiology Department - NMR Research - Oncology Section Johns Hopkins University School of Medicine, Baltimore, MD, USA |
|
|
|
| 17:45 - 18:20 |
|
Alternative Splicing in Tumors: Detection and Interpretation
Terry Speed
Department of Statistics and Program in Biostatistics University of California, Berkeley, CA, USA |
| 18:20 - 18:40 |
|
A Bioinformatics Approach to the Molecular Systematics of Lymphoma
Stefan Bentink
Institute of Functional Genomics Division of Bioinformatics University of Regensburg, Germany |
| 18:40 - 19:15 |
|
Integrated Bioinformatics for Deciphering Complex Pathomechanisms in Cancer
Roland Eils
Theoretical Bioinformatics Department German Cancer Research Center Heidelberg, Germany |
| 20:00 |
|
Get together and dinner at the Pinakothek der Moderne |
|
|
|
| 8:00 - 18:00 |
|
Registration, Lobby of the Auditorium Maximum |
|
|
|
| 8:30 - 9:05 |
|
Wnt Signaling Modulates Intestinal and Mammary Cancer
Stemness and Malignant Behavior
Riccardo Fodde
Department of Pathology, Josephine Nefkens Institute Erasmus University, Rotterdam, The Netherlands |
| 9:05 - 9:40 |
|
Therapeutic and Prognostic Potential Role of Cancer Stem Cells
Ruggero De Maria
Istituto Superiore di Sanità Rome, Italy |
| 9:40 - 10:15 |
|
The Role of HER2 and PTEN in Normal and Malignant Stem Cell Self-Renewal and
the Herceptin Resistance
Hasan Korkaya
University of Michigan Comprehensive Cancer Center Ann Arbor, MI, USA |
| 10:15 - 10:50 |
|
Do Malignant Peripheral Nerve Sheath Tumors Arise from Endogenous Stem Cells?
Jack T. Mosher
Center for Stem Cell Biology HHMI / University of Michigan, Ann Arbor, MI, USA |
| 10:50 - 11:15 |
|
Coffee Break - Visit also the Exhibition and Posters |
|
|
|
| 11:15 - 11:50 |
|
Novel Molecular Targets in Acute Myeloid Leukemia
Christian Brandts
Dept. of Medicine, Hematology / Oncology University of Frankfurt, Frankfurt, Germany |
| 11:50 - 12:25 |
|
Cellular Senescence in Lymphoma Development and Therapy
Clemens A. Schmitt
Hematology, Oncology, and
Tumor Immunology Charité - Universitätsmedizin Berlin
(CVK), and Max-Delbrück-Center for Molecular Medicine Berlin,
Germany |
| 12:25 - 12:55 |
|
Rapid high-resolution karyotyping by combining
genome-wide SNP-mapping with exon expression arrays: An applied systems biology
approach for cancer research
Dr. Matthias Prucha, Senior Application Specialist
Affymetrix
(Sponsor of the Lunch Break) |
| 12:55 - 14:00 |
|
Lunch Break |
|
|
|
| 14:00 - 14:30 |
|
Therapeutic Antibodies in Oncology - Epitopes and Functions Discovery Oncology
Dr. Hans-Joachim Müller
Roche Penzberg, Germany |
| 14:30 - 15:00 |
|
mTOR as a Promising Target for Cancer Therapy
Edward K. Geissler
Department of Surgery University of Regensburg, Regensburg, Germany |
| 15:00 - 15:30 |
|
Molecular Definition of the Therapeutic Action of the Multi-Targeted Drug
SUTENT/ Sunitinib
Michaela Bairlein
Max Planck Institute of Biochemistry Martinsried, Germany |
| 15:30 - 16:00 |
|
Coffee Break - Visit also the Exhibition and Posters |
|
|
|
| 16:00 - 16:35 |
|
Warburg Revisited: The Role of Glucose Metabolism in Cancer Immunology
Marina Kreutz
Experimental Hematology and Oncology, University of Regensburg, Germany |
| 16:35 - 17:10 |
|
A Pivotal Role for p53: Balancing Aerobic Respiration and Glycolysis
Paul M. Hwang
National Heart, Lung, and Blood Institute, Cardiology Branch Bethesda, MD, USA |
| 17:10 - 17:45 |
|
Metabolic Restraint of T Lymphocyte Activation and Migration
by Tumor-Conditioned Myeloid Cells
Vincenzo Bronte
Istituto Oncologico Veneto, Padova, Italy |
| 17:45 - 18:20 |
|
TNF-Induced Tumor Ganglioside Synthesis as a Mechanism of Immune Evasion by Tumors
Charles Tannenbaum
Lerner Research Institute Department of Immunology, Cleveland, OH, USA |
| 18:20 - 18:55 |
|
Genetic Regulation and Therapeutic Correction of Immune Escape in Cancer
George C. Prendergast
Lankenau Institute for Medical Research, Wynnewood, PA, USA |
| 18:55 - 19:30 |
|
Immune Contexture and Clinical Outcome in Colorectal Cancer
Jerome Galon
Inserm U872, Cordeliers Research Center, Paris, France |
| 20:00 |
|
Bavarian Dinner |
|
|
|
| 8:00 - 12:00 |
|
Registration, Lobby of the Auditorium Maximum |
|
|
|
| 8:30 - 9:05 |
|
Integrated Biological and Epidemiological Models of Carcinogenesis
William G. Thilly
Massachusetts Institute of Technology, Cambridge, MA, USA |
| 9:05 - 9:25 |
|
Transcriptional Profiling of Single Disseminated Breast Cancer Cells
Claudia Hartmann
Department of Oncogenomics University of Regensburg, Regensburg, Germany |
| 9:25 - 10:00 |
|
Modeling and Mining Cancer Genomes
Zhihu Ding
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| 10:00 - 10:20 |
|
Genetic Characterization of Metastatic Precursor Cells in Prostate Cancer
Bernhard Polzer
Department of Oncogenomics University of Regensburg, Regensburg, Germany |
| 10:20 - 10:45 |
|
Coffee Break - Visit also the Exhibition and Posters |
| 10:45 - 11:20 |
|
Genetic Susceptibility to Colorectal Cancer
Richard S Houlston
Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK |
| 11:20 - 11:40 |
|
The ATM Gene in Familial Breast Cancer
Anne Hartmann
Institute of Functional Genomics University of Regensburg, Germany |
| 11:40 - 12:15 |
|
Genetic Epidemiology of Colorectal and Prostate Cancer -
From Candidate Pathways towards a Genome-Wide Approach
Ulrike Peters
Fred Hutchinson Cancer Research Center, Seattle, WA, USA |
| 12:15 - 13:30 |
|
Lunch Break |
|
|
|
| 13:30 - 14:05 |
|
Tumor and Lymph Node Lymphangiogenesis: Impact onCancer Metastasis
Michael Detmar
Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, Zurich, Switzerland |
| 14:05 - 14:40 |
|
Tumor Antigens and Preclinical Models for Cancer Immunotherapy
Benoit Van den Eynde
Ludwig Institute for Cancer Research, Brussels, Belgium |
| 14:40 - 15:15 |
|
Novel Molecular Defects in Acute Lymphoblastic Leukemia
Jan Cools
VIB Department of Molecular and Developmental Genetics, Katholieke Universiteit Leuven, Belgium |
| 15:15 - 15:50 |
|
A Genomic Strategy to Personalize Breast Cancer Therapy
Anil Potti
Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC, USA |
| 15:50 - 16:00 |
|
Closing Remarks by Peter Oefner |
|
|
|
|
|
Walter Kolch ACCEPTED
Beatson Institute for Cancer Research
Glasgow, UK
Email: wkolch@beatson.gla.ac.uk
Lukas Huber, MD ACCEPTED
Biocenter, Division of Cell Biology
Innsbruck Medical University
Austria
E-mail: Lukas.A.Huber@i-med.ac.at
Ivan Dikic, MD, PhD ACCEPTED
Institute of Biochemistry II
Goethe University Medical School
Frankfrut am Main, Germany
E-mail: Ivan.Dikic@biochem2.de
Richard Marais, PhD ACCEPTED
The Institute of Cancer Research
London
Email: richard.marais@icr.ac.uk
Roderick L. Beijersbergen, PhD ACCEPTED
The Netherlands Cancer Institute
Amsterdam, The Netherlands
Email r.beijersbergen@nki.nl
Bernard Mathey-Prevot, Ph.D. ACCEPTED
Drosophila RNAi Screening Center
Harvard Medical School
Boston, USA
Email: bprevot@receptor.med.harvard.edu
|
|
|
Prof. Dr. rer. nat. Axel Ullrich ACCEPTED
Max Planck Institute of Biochemistry
Martinsried, Germany
E-mail: ullrich@biochem.mpg.de
Prof. Dr. Juergen Behrens ACCEPTED
Nikolaus-Fiebiger-Center of Molecular Medicine
University Erlangen
Erlangen, Germany
E-mail jbehrens@molmed.uni-erlangen.de
|
|
|
Dr. Friedrich Lottspeich ACCEPTED
Max Planck Institute of Biochemistry
Martinsried, Germany
E-mail: lottspei@biochem.mpg.de
Prof. Dr. Anja Katrin Bosserhoff ACCEPTED
Universität Regensburg
Institut für Pathologie
Molekulare Pathologie
Regensburg, Germany
Email: anja.bosserhoff@klinik.uni-regensburg.de
|
|
|
|
Prof. Dr. Andreas H. Jacobs, MD ACCEPTED
Department of Neurology
Klinikum Fulda gAG, Germany and
Laboratory for Gene Therapy and Molecular Imaging
MPI for Neurological Research, Cologne
Email: andreas@nf.mpg.de
Kristine Glunde, Ph.D. ACCEPTED
Johns Hopkins University School of Medicine
Baltimore, USA
e-mail: kglunde@mri.jhu.edu
|
|
|
Prof. Terry Speed ACCEPTED
University of California at Berkeley
Berkeley, USA
email: terry@stat.berkeley.edu
Stefan Bentink ACCEPTED
Institute of Functional Genomics
University of Regensburg
Regensburg, Germany
Email: Stefan.Bentink@klinik.uni-regensburg.de
Prof. Roland Eils ACCEPTED
Theoretical Bioinformatics Department
German Cancer Research Center
Heidelberg, Germany
Roland Eils: R.Eils@dkfz.de
|
|
|
|
|
|
|
|
|
|
Riccardo Fodde ACCEPTED
Dept. of Pathology,
Josephine Nefkens Institute,
Erasmus University Medical Center,
Rotterdam, The Netherlands
Email: r.fodde@erasmusmc.nl
Ruggero De Maria ACCEPTED
Istituto Superiore di Sanità
Roma, Italy
Email: rdemaria@tin.it
Hasan Korkaya, Ph.D. ACCEPTED
Int Med-Hematology/Oncology
University of Michigan
Ann Arbor,USA
Email: hkorkaya@med.umich.edu
Jack T. Mosher, Ph.D. ACCEPTED
Center for Stem Cell Biology
University of Michigan
Ann Arbor, USA
Email: mosherjt@umich.edu
|
|
|
Prof. Christian Brandts ACCEPTED
Dept. of Medicine, Hematology / Oncology
University of Muenster
Muenster, Germany
Email: cbrandts@uni-muenster.de
Prof. Dr. Clemens A. Schmitt, M.D. ACCEPTED
Hematology, Oncology, and Tumor Immunology
Charité - Universitätsmedizin Berlin (CVK), and
Max-Delbrück-Center for Molecular Medicine
Berlin, Germany
E-mail: clemens.schmitt@charite.de
|
|
|
Dr. Hans Joachim Müller ACCEPTED
Disxovery Onkologie
Roche Penzberg, Germany |
|
|
|
Edward K. Geissler, PhD ACCEPTED
University of Regensburg
Department of Surgery
Regensburg, Germany
e-mail: edward.geissler@klinik.uni-regensburg.de
Michaela Bairlein ACCEPTED
Max Planck Institute of Biochemistry
Martinsried, Germany
E-mail: bairlein@biochem.mpg.de
|
|
|
Prof. Dr. Marina Kreutz ACCEPTED
Universitätsklinik Regensburg
Experimentelle Hämatologie und Onkologie
Regensburg, Germany
Email: marina.kreutz@klinik.uni-regensburg.de
Paul M. Hwang, M.D., Ph.D. ACCEPTED
Cardiology Branch
Bethesda
Email: hwangp@mail.nih.gov
Vincenzo Bronte, MD ACCEPTED
Istituto Oncologico Veneto
Padova, Italy
Email: enzo.bronte@unipd.it
Charles Tannenbaum, PhD ACCEPTED
Lerner Research Institute
Department of Immunology
Cleveland Clinic Foundation
Cleveland, USA
Email: TANNENC@ccf.org
George C. Prendergast, PhD ACCEPTED
Lankenau Institute for Medical Research
Wynnewood, USA
Email: prendergast@limr.org
Jerome GALON, PhD ACCEPTED
Inserm U872, Cordeliers Research Center
Paris, France
Email: jerome.galon@crc.jussieu.fr
|
|
|
|
|
|
|
|
|
|
Prof. William G. Thilly ACCEPTED
Massachusetts Institute of Technology
Cambridge, USA
Email: thilly@mit.edu
Dr. Claudia Hartmann ACCEPTED
Institut für Pathologie
Klinikum der Universität Regensburg
Regensburg, Germany
Email: Claudia.hartmann@klinik.uni-regensburg.de
Dr. Bernhard Polzer ACCEPTED
Institut für Pathologie
Klinikum der Universität Regensburg
Regensburg, Germany
Email: bernhard.polzer@klinik.uni-regensburg.de
Richard S. Houlston ACCEPTED
Institute of Cancer Research
Surrey, UK
Email: Richard.Houlston@icr.ac.uk
Dr. Anne Hartmann ACCEPTED
Institute of Functional Genomics
University of Regensburg, Germany
Email: anne.hartmann@klinik.uni-regensburg.de
Ulrike Peters, Ph.D. ACCEPTED
Fred Hutchinson Cancer Research Center
Department of Epidemiology, University of Washington
Seattle, USA
Email: upeters@fhcrc.org
|
|
|
|
|
Michael Detmar, MD ACCEPTED
Institute of Pharmaceutical Sciences
Swiss Federal Institute of Technology (ETH)
Zurich, Switzerland
Email: michael.detmar@pharma.ethz.ch
Benoi Van den Eynde, M.D., Ph. D. ACCEPTED
Ludwig Institute for Cancer Research
Brussels, Belgium
Email: vandeneynde@licr.ucl.ac.be
Jan Cools, PhD ACCEPTED
VIB Department of Molecular and Developmental
Genetics
Leuven, Belgium
E-mail: jan.cools@med.kuleuven.be
Anil Potti, MD ACCEPTED
Duke Institute for Genome Sciences and Policy
Division of Medical Oncology
Durham, UK
Email: anil.potti@duke.edu
|
|
|
|
|
|
